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Abstract: Phosphorous-containing molecules are essential constituents of all living cells.
While the phosphate functional group is very common in small molecule natural products, nucleic acids,
and as chemical modification in protein and peptides, phosphorous can form P–N (phosphoramidate),
P–S (phosphorothioate), and P–C (e.g., phosphonate and phosphinate) linkages. While rare, these
moieties play critical roles in many processes and in all forms of life. In this review we thoroughly
categorize P–N, P–S, and P–C natural organophosphorus compounds. Information on biological source,
biological activity, and biosynthesis is included, if known. This review also summarizes the role of
phosphorylation on unusual amino acids in proteins (N- and S-phosphorylation) and reviews the natural
phosphorothioate (P–S) and phosphoramidate (P–N) modifications of DNA and nucleotides with
an emphasis on their role in the metabolism of the cell. We challenge the commonly held notion that
nonphosphate organophosphorus functional groups are an oddity of biochemistry, with no central role
in the metabolism of the cell. We postulate that the extent of utilization of some phosphorus groups
by life, especially those containing P–N bonds, is likely severely underestimated and has been largely
overlooked, mainly due to the technological limitations in their detection and analysis.
Keywords: P–N bond; phosphoramidate; N-phosphorylation; P–S bond; phosphorothioate;
S-phosphorylation; P–C bond; phosphonate; phosphinate; phosphine
1. Introduction
All life on Earth relies on phosphorous-containing compounds in metabolism. Phosphate esters
(C-O-P) in particular play a central, uniting role for all living organisms on Earth. They are not
only crucial building blocks of genetic material (DNA and RNA) but also act as a main energy
transfer medium for the great majority of the metabolic processes of the living cell. Phosphate esters
also participate in a highly organized regulation of other metabolic processes (e.g., in protein
phosphorylation and in signaling molecules such as cAMP and in enzyme cofactors). The importance
and advantageous properties of phosphate esters are also discussed at length in the context of the origin
of life on Earth and its early evolution [1–3]. Due to the dominating role of the phosphate esters in
biochemistry and genetics it is not surprising that phosphate esters have been the central focal point of
biological research for more than a century.
Perhaps it is therefore not surprising that for many years the critical roles of nonphosphate classes
of phosphorous-containing biochemicals in maintaining cellular homeostasis were often overlooked.
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In addition to phosphate ester functional group, life also makes P–N (phosphoramidate) (Section 2),
P–S (phosphorothioate) (Section 3), and P–C (e.g., phosphonate and phosphinate) (Section 4) linkages.
In this review we thoroughly categorize the P–N, P–S, and P–C understudied natural
organophosphorus compounds (Throughout the paper, for consistency, all oxyacids are shown
in their protonated form; we note however that under physiological conditions one or more of
the hydroxyl groups attached to a phosphorus atom may be deprotonated). We provide a summary
of their biological source, biological activity, and biosynthesis, if known. We also discuss the role of
phosphorylation of unusual amino acids in proteins (N- and S-phosphorylation) as well as natural
phosphorothioate (P–S) and phosphoramidate (P–N) modifications of DNA and nucleotides with
an emphasis on their role in the metabolism of the cell. We challenge the commonly held notion
that these nonphosphate organophosphorus functional groups are an oddity of biochemistry, with
no central role in the metabolism of the cell. We postulate that the extent of utilization of some of
the ‘noncanonical’ phosphorus-containing functional groups by life (e.g., P–N bonds) has been severely
underestimated and largely overlooked. We hope that this review will stimulate further interest of
the broad scientific community in these understudied classes of compounds.
2. Natural Products Containing a P–N Bond (Phosphoramidates)
Traditionally compounds containing a nitrogen–phosphorus bond are divided into two separate
classes: I and II [4,5]. Compounds of class I are characterized by the presence of terminal P–OH group
(all N-phosphorylated amino acids in proteins belong to this group as well as many small molecules
e.g., phosphagen—N-phosphocreatine). On the other hand, compounds belonging to class II have
accessible terminal P–NH2 group (for example, adenosine 5′-phosphoramidate) (Figure 1).
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and small molecules containing a phosphorus-nitrogen single bond (P–N bond) are relatively rare in 
biochemistry and number only around 55 among known natural products (see Section 2.1 for more 
information on small-molecule natural products containing a P–N bond). However, the apparent 
rarity of a P–N bond among natural products and PTMs might be caused by biased methods of 
isolation and/or identification. For example, it might be prudent to revisit the commonly repeated 
notion that the phosphoramidate P–N bond is only rarely utilized by life. 
The phosphoramidate bond hydrolyzes quite readily in acidic conditions, which means that acid 
extraction of acidic chromatography solvents or column materials are liable to destroy such 
compounds. This might make the isolation or identification of phosphoramidates in the cell a 
challenge (see Section 2.2 for more information on N-phosphorylation of proteins and peptides). 
Recent advances in analytical techniques, especially protein mass spectrometry suggest that P–N 
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Figure 1. Phosphoramidates (bold font) are traditionally divided into two classes of compounds. Compounds
of class I are characterized by the presence of terminal P–OH group (e.g., phosphagen—N-phosphocreatine).
Compounds of class II are characterized by the presence of the accessible terminal P–NH2 group (e.g., adenosine
5′-phosphoramidate).
At the first glance, post-translational N-phosphorylation of amino acids in proteins (Section 2.2)
and small molecules containing a phosphorus-nitrogen single bond (P–N bond) are relatively rare in
biochemistry and number only around 55 among known natural products (see Section 2.1 for more
information on small-molecule natural products containing a P–N bond). However, the apparent rarity
of a P–N bond among natural products and PTMs might be caused by biased methods of isolation
and/or identification. For example, it might be prudent to revisit the commonly repeated notion that
the phosphoramidate P–N bond is only rarely utilized by life.
The phosphoramidate bond hydrolyzes quite readily in acidic conditions, which means that
acid extraction of acidic chromatography solvents or column materials are liable to destroy such
compounds. This might make the isolation or identification of phosphoramidates in the cell
a challenge (see Section 2.2 for more information on N-phosphorylation of proteins and peptides).
Recent advances in analytical techniques, especially protein mass spectrometry suggest that P–N bond
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biochemistry is critical to many core metabolic functions in all of life (discussed in Section 2, below).
P–N bond-containing phosphagens are central to energy metabolism, and have been known for
more than a century. Many N-phosphorylations of proteins have only recently been identified
as a widespread and critical part of the physiology of the cell. Both chemical groups are shared
among a multitude of evolutionary distant organisms. Below (in Sections 2.1 and 2.2) we present
an overview of the P–N biochemistry utilized by life and hypothesize that our current view on
the extent of life’s utilization of the P–N bond chemistry might be greatly underestimated.
2.1. Small-Molecule Natural Products Containing a P–N Bond
Natural products containing P–N bonds belonging to classes I and II can be further categorized
into two main, broad groups of molecules: phosphormonoamidates, containing one P–N bond and a
much less numerous, and a second group of molecules called phosphortriamidates, containing three
P–N bonds. Phosphordiamidates (with two P–N bonds) are not known to be produced by life. The only
known instances of the phosphordiamidates occur as catalytic intermediates (e.g., in the Histidine
Triad Nucleotide Binding (Hint) proteins (see Section 2.1.2 for more information on Hint proteins)) [6].
We discuss in detail all known small molecule natural products containing P–N bond below.
Phosphoramidate hydrazides: Three distinct natural phosphorus-containing hydrazides are known.
All of them are phosphormonoamidates with antibiotic properties. Antibacterial natural product
FR-900137 (1) was isolated from Streptomyces unzenensis from Japanese soil [7,8]. FR-900137 antibiotic is
active against both Gram-positive and Gram-negative bacteria [8]. Two other phosphormonoamidate
hydrazide antibiotics—fosfazinomycins A (2) and B (3)—were isolated from Streptomyces lavendofoliae
No. 630 [9]. It is important to note that compounds 2 and 3 apart from being classified as
phosphoramidates (P–N bond) also belong to a class of compounds called phosphonates (P–C bond)
(for more information on phosphonates see Section 4.1).
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Figure 2. Biosynthetic path ays for fosfazinomycins A (2) and B (3) as proposed in recent studies
by [10–12,15]. Putative steps are denoted by dashed lines.
Phosphosulfoximines: There are only few isolated reports on identification of the natural P–N phospho
derivatives of sulfoximines (monoaza analogs of sulfones). Two such molecules—4 and 5—were isolated
from a Streptomyces sp. [16,17]. All known natural sulfoximines have neurotoxic or antibiotic properties.
For a detailed review on natural sulfoximines and other N–S bond-containing natural products see [18].
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Phosphoramidon (11) and its stereoisomer talopeptin (12) (talopeptin differs from
phosphoramidon only by a single stereocenter, from 6-deoxymannose in phosphoramidon to
6-deoxytalose in talopeptin) were isolated from cultures of various Actinomycetes species including
Streptomyces tanashiensis and Streptomyces mozunensis MK2 [21]. Both compounds are inhibitors of
the thermolysin enzyme and other metalloproteinases [22–29].
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The pathogenic bacterium Campylobacter jejuni, known for being a major cause of bacterial
gastroenteritis worldwide, produces bacterial capsular polysaccharides (CPS) that are complex
carbohydrate structures containing P–N bonds. CPS are composed of chains of sugars that surround
the outer surface of the Campylobacter jejuni cells. CPS were shown to be instrumental in efficient
colonization and infection of the host organism including defense from bacteriophages and host immune
system [37–41]. A cluster of 35 genes is involved in biosynthesis and export of the CPS polysaccharides [42].
CPS are heavily chemically modified and many different Campylobacter jejuni strains produce strain-specific
structural variations of the CPS [43,44]. The most unusual of the chemical modifications of the CPS is
the incorporation of the unique O-methyl phosphoramidate modification on specific sugar residues
(2-acetamido-2-deoxy-β-D-galactofuranose—17, D-glycero-α-L-gluco-heptopyranose—18) which so far
have only been identified in Campylobacter sp. [43–45]. The biosynthetic pathway leading to the formation
of the P–N bond in CPS was only recently discovered [46–49]. The initial transformation in the biosynthetic
pathway for the phosphoramidate modification of the sugar residues in the CPS proceeds via direct
N-phosphorylation of the amide nitrogen of L-glutamine with ATP by a specific L-glutamine kinase
(EC 2.7.3.13) to form a N-phospho-L-glutamine (16) (Figure 3) [46–49].
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Figure 3. (A) The initial transformation in the biosynthetic pathway for the phosphoramidate
modification of the sugar residues in the bacterial capsular polysaccharides (CPS) proceeds via
direct phosphorylation of the amide nitrogen of L-glutamine with ATP by a specific L-glutamine
kinase (EC 2.7.3.13) to form N-phospho-L-glutamine (16). (B) Compound 16 is a precursor for
P–N bond-containing sugar residues (17, 18) of the CPS and it is proposed to undergo a series
of transformations before the formation of the final CPS product (with the formation of inorganic
phosphoramidate (33) and 3′-Phospho-5′-cytidine diphosphoramidate (34) as P–N bond-containing
intermediates) [46–49]. Enzymes from Campylobacter jejuni CPS biosynthetic gene cluster with
the known function in the CPS biosynthetic pathway are marked in bold font.
2.1.1. Phosphagens
Phosphagens are P–N containing used as en rgy reserv s in metabolism. We discuss
them in a separate subsection due to their uniting chemical haracteristic but also due to heir
convergent function i the molecular physiology of the c ll.
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Phosphagens’ main function in the cell is to alleviate an energy crisis when the demand for
energy is higher than the cellular ATP production capacity. Phosphagens act as an ATP buffer, being
made from ATP when ATP is abundant and being used to regenerate ATP from ADP when energy
demand outstrips the cell’s capacity to synthesize ATP. Phosphagens can accumulate in the tissue to
much higher intracellular concentrations than ATP [50]. In consequence the release of phosphate form
phosphagen molecules in high-energy demanding tissues has an additional indirect regulatory effect
on such basic, metabolic processes as glycolysis and glycogenolysis [50–52].
Phosphagens have been predominantly identified in the organisms belonging to the animal
kingdom of life. The muscle tissue of animals requires high levels of freely accessible energy
that has to be often released fast and in large amounts, this could lead to situations when ATP
production is insufficient to meet the energetic needs of the animal muscle tissue (e.g., during fast rapid
movements). However the phosphagen systems were also identified in single-celled organisms,
like eukaryotic ciliates and flagellates [53–55] and even bacteria [53–55] (see below and Table 1
for an exhaustive list of phosphagens, their respective kinases, and organisms where they were
characterized). The identification of phosphagen systems in unicellular organisms shows that
phosphagens are used ubiquitously and possibly universally to mitigate physiological high energy
demands. Such phosphagen-mediated fulfillment of high energy demands applies not only to complex
tissues of multicellular organisms but also to individual organelles within the single cell. Phosphagen
kinases of unicellular organisms are localized mainly in the ciliary region of the cell. Such localized
concentration of phosphagens in the flagellar and ciliary regions likely enables an uninterrupted,
continuous supply of energy to dynein and therefore enables a continuous ciliary movement [56,57].
It is generally proposed that arginine and creatine kinases were the ancestral phosphagen kinases
(e.g., see work by Conejo [58]). However, our understanding of the evolutionary history of phosphagen
systems is far from complete. For example, the discovery of phosphagen kinases (taurocyamine kinase
and agmatine kinase), other than arginine kinase, in unicellular organisms (Phytophthora infestans,
Ochromonas danica, and Euglena oracilis) signifies the complexity of the evolutionary history of these
molecules [53–55].
The biosynthetic pathways differ depending on the phosphagen and the source organism,
although the amino acid arginine is always the initial precursor for all phosphagens known to
date [51]. The last step in the biosynthetic pathways of different phosphagens follows the same
principle (Scheme 1).
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Sche e 1. The last step of the phosphagens’ biosynthetic path ay.
In the phosphagen biosynthetic pathway proto-phosphagens are guanidine group-containing
phosphate acceptor compounds. As a result of the phosphate transfer from the ATP molecule
the P–N phosphoramidate bond is formed between the phosphorus atom and a nitrogen atom of
the guanidine group, leading to the formation of the phosphagen product (Scheme 1). This final step
of the phosphagen biosynthesis is catalyzed by specific phosphagen kinases. Phosphagen kinases are
enzymes that catalyze the reversible Mg2+-dependent transfer of the gamma phosphoryl group of ATP
to a naturally occurring guanidino compounds, proto-phosphagens, such as creatine, glycocyamine,
taurocyamine, lombricine, and arginine. Phosphagen kinases are a highly conserved family of proteins
that nevertheless differ significantly with respect to their enzyme specificity and protein structure
(monomeric, dimeric, and oligomeric forms of phophagen kinases are known) and distribution in
the cell [59–70]. Among the most studied phosphagen kinases is the creatine kinase (EC 2.7.3.2),
which is the only known phosphagen kinase to exist in vertebrates [71–74]. In contrary to creatine
kinase, the arginine kinase (EC 2.7.3.3) is most widely distributed, occurring in invertebrates [75]
and even in several unicellular organisms [56,76], including strains of proteobacteria like Desulfotalea
psychrophila, Myxococcus xanthus, Moritella sp. PE36, and Sulfurovum sp. NBC37-1 [53–55] (Table 1).
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It is still debated if bacterial arginine kinases identified in those few species are evidence of ancient
evolutionary history of N-phosphoarginine and phosphoramidates or have been acquired by horizontal
gene transfer from eukaryotes [53–55]. Other, less studied phosphagen kinases that were identified
in invertebrates include hypotaurocyamine kinase (EC 2.7.3.6) [77], so far identified only in peanut
worms [78], glycocyamine kinase (EC 2.7.3.1), lombricine and thalessemine kinases (EC 2.7.3.5),
opheline kinase (EC 2.7.3.7), and taurocyamine kinase (EC 2.7.3.4) [51,79,80], identified mostly
in annelids with several potential examples identified in trematodes [59,81–89] and unicellular
oomycetes [51,79,80]. One phosphagen kinase, agmatine kinase (EC 2.7.3.10), appears to be specific
only to protozoa [90] (Table 1).
It is notable that, as of yet, the phosphagen systems are not known to exist in plants, fungi, and in
the majority of species of prokaryotic domains of life. Several studies attempted metabolic inverse
engineering of Escherichia coli and Saccharomyces cerevisiae with the arginine kinase phosphagen system
(both species are not known to produce phosphagens naturally) [91–93]. In both cases the engineered
strains gained significant advantage in mitigating the adverse effects of low pH stress than their
wild type counterparts [91–93]. It is conceivable that the extra boost of energy from the accumulated
N-phosphoarginine (19) allowed for much more rapid recovery of arginine kinase-expressing strains
of Escherichia coli and Saccharomyces cerevisiae [91]. These results show that at least in the case of
N-phosphoarginine (19) the phosphagen system can be transferred directly to phylogenetically distant
species by simple overexpression of arginine kinase with immediate beneficial effects for the modified
organism [91].
There are nine phosphagens known. See Table 1 for an exhaustive list of phosphagens
and the information on characterization of their respective kinases and organisms where they were
originally identified.
1. N-phosphoagmatine (24) is a phosphagen identified in protozoa Euglena oracilis
and Ochromonas danica [90]. As in the case of other phosphagens, a specific agmatine
kinase (EC 2.7.3.10) is responsible for the synthesis of N-phosphoagmatine (24), with L-arginine
also being phosphorylated but much less efficiently [90].
2. N-phosphoopheline (26) is a phosphagen identified in the marine annelid Ophelia neglecta.
The main function of the opheline kinase (EC 2.7.3.7) is the synthesis of the phosphagen
N-phosphoopheline, however the substrate specificity of (EC 2.7.3.7) is much broader than
other phosphagen kinases and (EC 2.7.3.7) can also phosphorylate taurocyamine, lombricine,
and taurocyamine albeit with lower efficiency [94].
3. N-phospholombricine (25) is a phosphagen identified in several invertebrate species,
mostly annelids, e.g., earthworms [95–98]. The compound 25 is synthetized by the lombricine
kinase (EC 2.7.3.5) which specificity varies with respect to the source species the enzyme was
isolated from [63,99–101]. It is worth noting that different, evolutionarily distant, organisms
can produce the same phosphagens that only differ in the stereoisomer of one component
residue. For example, N-phospholombricine in majority of annelids contains a D-serine residue
while the N-phospholombricine of echiuroids, a group of marine worms contains an L-serine
moiety [51,79].
4. N-phosphoguanidinoacetate (N-phosphoglycocyamine) (23) is a phosphagen identified in many
invertebrate species, mainly annelids. The compound 23 is synthetized by the guanidinoacetate
kinase (also named glycocyamine kinase; EC 2.7.3.1). Guanidinoacetate kinase participates in
arginine and proline metabolism in the cell and is widely distributed across the invertebrate
branch of the tree of life. The glycocyamine kinases (EC 2.7.3.1) from the annelid Hediste diversicolor
was also shown to be responsible for the synthesis of the N-phosphoguanidine (28), however it is
unclear if N-phosphoguanidine (28) is a true endogenous phosphagen of Hediste diversicolor or any
other species [102]. While it is theoretically possible for N-phosphoguanidine to be formed in vivo
and for compound 28 to be an important metabolite in the cell its importance in the cellular
metabolism remains to be proven.
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5. N-phosphothalassemine (27) is a phosphagen structurally similar to lombricine.
N-phosphothalassemine (27) was isolated from a common earthworm Lumbricus terrestris
and an unsegmented marine worm Thalassema thalassema [103]. The phosphagen kinase EC 2.7.3.5,
responsible for phosphorylation of lombricine, is also responsible for phosphorylation of methylated
lombricines such as thalassemine [103].
6. N-phosphohypotaurocyamine (22) is a rare sulfinic acid phosphagen so far identified only in
peanut worms (Golfingia sp.) [78,104]. Hypotaurocyamine kinase (EC 2.7.3.6) responsible for
the synthesis of N-phosphohypotaurocyamine has high preference towards hypotaurocyamine,
although it can also phosphorylate taurocyamine, albeit with diminished efficiency [77]. It is
suggested that this unusual phosphagen system evolved from molluscan N-phosphoarginine
kinase [78].
7. N-phosphotaurocyamine (21) is a sulfonic acid phosphagen synthesized by a widespread
taurocyamine kinase (EC 2.7.3.4) identified in a large number of annelid species [59,81–85].
However, recent identification of taurocyamine kinases in a large number of non-annelid
species, including trematodes Paragonimus westermani, Schistosoma japonicum, Clonorchis
sinensis [82,83,86–89] and, in two isolated cases in unicellular oomycetes [82,83,86–89],
suggests that the evolutionary and phylogenetic scope of alternative substrate specificities of
phosphagen kinases may be more widespread than previously thought [105].
8. N-phosphoarginine (19) phosphagen is as widespread among invertebrates as N-phosphocreatine
(20) is widespread among vertebrate species. Arginine kinase (EC 2.7.3.3), responsible for
phosphorylation of arginine, also occurs in unicellular organisms like protists and even bacteria
which could suggest evolutionary ancient origins of N-phosphoarginine phosphagen system.
Indeed, N-phosphoarginine phosphagen system appears to be the earliest one developed by
life on Earth and at least couple of other phosphagen systems derive their evolutionary history
from an earlier version of the N-phosphoarginine phosphagen system [51,54,58,75,105–108].
Interestingly D-arginine is a substrate for Sabellastarte indica D-arginine kinase [109,110].
9. N-phosphocreatine (20) is a phosphagen synthesized by creatine kinase (EC 2.7.3.2).
N-phosphocreatine (20) is produced both by vertebrates and invertebrates (Table 1). Compound
20 functions as a rapid reserve of high-energy phosphates to recycle ATP in high-energy demand
tissues such as the brain or skeletal muscle and was mostly studied in mammals [111–113].
The chemical properties, functions, and clinical relevance of N-phosphocreatine (20) and its
corresponding kinase were reviewed extensively elsewhere and will not be expanded
here [106,114–117]. In brief, N-phosphocreatine is crucial for normal vertebrate physiology,
not only on the whole organ level, e.g., in normal muscle activity, but also on the individual
cellular level, e.g., in the formation of the ‘creatine kinase circuit’ that is essential for
high-sensitivity hearing, as demonstrated by an unexpected hearing loss in creatine kinase
knockout mice experiments [118].
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Table 1. Natural occurrence and biochemical and structural characterization of phosphagens and phosphagen kinases.
Phosphagen Natural Occurrence and Biochemical and Structural Characterization of the Phosphagen Kinases
Domain, Kingdom
(or other) Phylum Class Species * Reference
N-phospho-arginine (19)
Animalia
Arthropoda
Insecta Anasa tristis, Periplaneta americana, Solenopsis invicta, Cissites cephalotes,
Plodia interpunctella, Manduca sexta, Locusta migratoria, Ctenocephalides felis,
Lucilia cuprina, Apis mellifera, Bombyx mori, Ctenocephalides felis,
Drosophila melanogaster, Musca domestica, Phormia regina,
Frankliniella occidentalis
[119–135]
Arachnida Polybetes pythagoricus, Holocnemus pluchei, Palamneus phipsoni [70,136,137]
Branchiopoda Daphnia magna [138]
Chelicerata Limulus polyphemus [66,139,140]
Maxillopoda Amphibalanus amphitrite [141]
Malacostraca Litopenaeus vannamei, Metapenaeus ensis, Neocaridina denticulata,
Euphausia superba, Macrobrachium rosenbergii, Marsupenaeus japonicus,
Pleocyemata sp., Portunus trituberculatus, Procambarus clarkii, Scylla serrata
[68,142–153]
Mollusca
Bivalvia Crassostrea gigas, Chlamys farreri, Ensis directus, Calyptogena kaikoi,
Corbicula japonica, Solen strictus, Pecten maximus, Archivesica packardana,
Scapharca broughtonii
[154–164]
Cephalopoda Sepia pharaonis, Amphioctopus fangsiao, Nautilus pompilius,
Octopus vulgaris, Sepioteuthis lessoniana, Sthenoteuthis oualaniensis
[165–169]
Gastropoda Semisulcospira libertina, Biomphalaria glabrata [170,171]
Cnidaria Anthozoa Nematostella vectensis, Anthopleura japonicus, Paracorallium japonicum,
Corallium rubrum
[67,172–174]
Annelida Polychaeta Myzostoma cirriferum, Sabellastarte indica [109,110,175]
Bryozoa Gymnolaemata Bugula neritina [176]
Echinodermata
Holothuroidea Stichopus japonicus, Isostychopus badonotus, Molpadia arenicola [64,177–179]
Echinoidea Strongylocentrotus purpuratus, Heliocidaris crassispina,
Hemicentrotus pulcherrimus, Paracentrotus lividus, Pseudocentrotus depressus
[178,180,181]
Crinoidea Tropiometra afra
Macrodiscus
[182]
Porifera Demospongiae Suberites domuncula, Clathria prolifera, Hartaetosiga gracilis, Suberites ficus [58,183]
Hexactinellida Aphrocallistes beatrix [58]
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Table 1. Cont.
Phosphagen Natural Occurrence and Biochemical and Structural Characterization of the Phosphagen Kinases
Domain, Kingdom
(or other) Phylum Class Species * Reference
Nematoda Chromadorea Heterodera glycines, Teladorsagia circumcincta, Steinernema
carpocapsae,Haemonchus contortus, Toxocara canis, Toxocara vitulorum,
Ascaris lumbricoides, Ascaris suum, Caenorhabditis elegans
[184–191]
Unranked Unranked Choanoflagellida Hartaetosiga gracilis, Monosiga brevicollis, Monosiga ovata [58]
Excavata Euglenozoa Kinetoplastea Trypanosoma brucei, Trypanosoma cruzi, Phytomonas Jma [69,192–196]
Alveolata Ciliophora Oligohymenophorea Paramecium caudatum, Paramecium tetraurelia, Tetrahymena pyriformis [56,76,197]
Bacteria Proteobacteria
Deltaproteobacteria Desulfotalea psychrophila, Myxococcus xanthus [53,55,198]
Epsilonproteobacteria Sulfurovum lithotrophicum [54]
N-phospho-creatine
(20) Animalia
Chordata
Cephalaspidomorphi Lampetra japonica [199]
Actinopterygii Danio rerio, Chaenocephalus aceratus, Clupea harengus, Cyprinus carpio,
Gadus morhua, Lepomis cyanellus, Oncorhynchus mykiss, Pagrus major,
Scomber japonicus
[74,200–209]
Chondrichthyes Torpedo californica, Discopyge tschudii, Ginglymostoma cirratum,
Scylliorhinus canicula
[210–213]
Amphibia Xenopus laevis [214]
Reptilia Pelodiscus sinensis, Trachemys scripta [209,215]
Aves Columba livia, Gallus gallus [216,217]
Mammalia Bos taurus, Canis lupus familiaris, Homo sapiens, Mus Musculus,
Eidolon helvum, Equus caballus, Oryctolagus cuniculus, Physeter catodon,
Rattus norvegicus, Urocitellus richardsonii
[117,199,211,218–
225]
Annelida Polychaeta Namalycastis sp., Neanthes diversicolor, Chaetopterus variopedatus, [199,226,227]
Cnidaria Anthozoa Nematostella vectensis, Dendronephthya gigantea [172,199]
Echinodermata Echinoidea Strongylocentrotus purpuratus, Heliocidaris crassispina,
Hemicentrotus pulcherrimus, Paracentrotus lividus, Pseudocentrotus depressus
[180,181,228–
230]
Porifera Demospongiae Tethya aurantia [231]
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Table 1. Cont.
Phosphagen Natural Occurrence and Biochemical and Structural Characterization of the Phosphagen Kinases
Domain, Kingdom
(or other) Phylum Class Species * Reference
N-phospho-taurocyamine
(21)
Animalia
Platyhelminthes Termatoda Schistosoma mansoni, Schistosoma japonicum [59,86,88]
Rhabditophora Paragonimus westermani, Clonorchis sinensis [82,83,87,89]
Annelida Polychaeta Arenicola brasiliensis, Riftia pachyptila, Arenicola marina [81,84,85]
Chromista Heterokontophyta Oomycota Phytophthora infestans, Phytophthora sojae [232–234]
N-phospho-hypotaurocyamine
(22)
Animalia Sipuncula Sipunculidea Golfingia vulgaris, Golfingia elongata, Siphonosoma cumanense [77,78,104]
N-phospho-glycocyamine
(23) Animalia
Annelida Polychaeta Namalycastis sp., Nephtys hombergii, Neanthes diversicolor,
Myxicola infundibulum, Nephtys caeca, Perinereis brevicirrus
[60,102,226,235–
239]
Platyhelminthes Rhabditophora Polycelis cornuta [239]
N-phospho-agmatine
(24)
Chromista Ochrophyta Chrysophyceae Ochromonas danica [90]
Excavata Euglenozoa Euglenoidea Euglena gracilis [90]
N-phospho-lombricine
(25) Animalia Annelida
Echiura Urechis caupo [63,240]
Clitellata Octolasium cyaneum, Allolobophora caliginosa, Lumbricus terrestris,
Eisenia fetida, Enchytraeus sp., Stylaria sp., Lumbriculus variegatus,
Tubifex tubifex, Megascolides cameroni
[75,95,96,99–101,
241,242]
N-phospho-opheline
(26)
Animalia Annelida Polychaeta Ophelia neglecta [94]
N-phospho-thalassemine
(27)
Animalia Annelida Clitellata Lumbricus terrestris [103]
* Species listed in bold font are known to produce more than one type of phosphagen. It is not unheard of for many organisms to utilize more than one type of phosphagen. For example,
sea urchin Strongylocentrotus purpuratus produces both N-phosphoarginine (19) and N-phosphocreatine (20). Another example is a multiphosphagen system in Namalycastis sp.,
where cytoplasmic creatine and glycocyamine kinases work together and complement the mitochondrial creatine kinase. The resulting high levels of N-phosphocreatine (20)
and N-phosphoglycocyamine (23) allow for a very quick response to sudden high energy requirements [226].
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After more than a hundred years of research focused on unraveling many functions of
phosphagens in living organisms, it is clear that the P–N bond-containing guanidine compounds
have rich and ancient evolutionary history and that they have a central role in the physiology
and biochemistry of all high-energy demanding life, single- or multicellular.
Cyclic phosphoguanidines: We note that the structures of some phosphagens can undergo
cyclization under acidic conditions to yield, e.g., glycocyamidine, creatinine, and their N-phosphorylated
derivatives N-phosphoglycocyamidine (29) and N-phosphocreatinine (30) [112,243,244]. For example,
it was postulated that 20–25% of the in vivo conversion of N-phosphocreatine (20) into creatinine may
proceed via an intermediate, N-phosphocreatinine (30) [111,245]. However, the true physiological levels
of N-phosphocreatinine are still uncertain. It appears that in rabbit white skeletal muscles the levels of
N-phosphocreatinine (30) reach 0.4% of the levels of N-phosphocreatine (20) [111].
A compound structurally similar to N-phosphocreatinine (30) called dimethyl-N2
-creatininylphosphate (31) was isolated from the sponge Ulosa ruetzleri collected from the inshore waters
of Harrington Sound, Bermuda [246].
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Auxenochlorella pyrenoidosa [248] but was subsequently identified in cell extracts of many other
organisms including Escherichia coli, Dictyostelium discoideum, Euglena gracilis, Spinacia oleracea,
and Hordeum vulgare [247]. However, despite being identified in a multitude of species the function of
AMPN is unknown.
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Early studies also postulated the existence of the phenylalanine adenylyltransferase (EC 2.7.7.54):
an enzyme that catalyses the reaction of ATP with L-phenylalanine to produce pyrophosphate
and N-adenylyl-L-phenylalanine in the biosynthetic pathway of the alkaloid cyclopeptin in Penicillium
cyclopium [254,255]. However, since then, the existence of this enzymatic activity was questioned
and currently BRENDA enzyme information system lists the enzymatic activity of EC 2.7.7.54 as part
of EC 6.3.2.40, which does not involve formation of any products and intermediates containing
P–N bonds [256]. More recent studies revised the biosynthetic pathway of cyclopeptin and further
questioned the formation of a P–N bond metabolite during cyclopeptin biosynthesis [257].
Less controversial is the existence of N-adenylyl-L-lysine residues (35) either as a covalent
enzyme substrate intermediates in DNA ligase (NAD+-dependent) (EC 6.5.1.2) in Escherichia coli
and RNA ligase of wheat germ [258] or as substrates of the evolutionarily conserved Hint and Hint2
family of AMP/GMP phosphoramidate hydrolases (36, 37) [259–263]. Hint proteins are enzymes
catalyzing the purine phosphoramidate hydrolysis. They hydrolyze the P–N bond in substrate
molecules containing an AMP/GMP-NH2 scaffold, for example, N-adenylyl-lysine residues (35),
into AMP and a free amine (or ammonia) [263–265]. Hint proteins are highly conserved in evolution
and are present in virtually every clade of life of Earth [266]. However, their exact biological role is not
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known. It is likely that the substrate specificity of AMP/GMP phosphoramidate hydrolases extends
beyond lysine, towards other AMP/GMP P–N-linked amino acids [263,264].
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Canonical stearic and palmitic acid dinogunellins (38, 39) and their structurally related putative
cousins—dinogunellins A-D (40–43)—are adenosine-containing phospholipids. Originally, dinogunellins
were detected in the mature eggs of several fish, e.g., in cabezon (Scorpaenichthys marmoratus) or northern
blenny roe (Stichaeus grigorjewi), as well as in the blood of eels (Anguilliformes) [267–269]. The distinctive
presence of a phosphoramidate P–N bond in dinogunellins is a recurring chemical feature that is widely
shared among many nucleotidic antibiotics, e.g., phosmidosines, the antifungal nucleotide antibiotics
from Streptomyces durhameusis (see below) [270,271]. In mature eggs of several fish dinogunellins occur
as a lipoproteins, complexed with the egg protein vitellogenin [272]. Interestingly they are absent in
immature eggs. The biological role of these compounds and the reason for their absence in the immature
fish eggs is not known (apart from their toxic effect that could be used as a defense against predation).
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Apart from early reports on the isolation of agrocin 84 (44) and dinogunellins (38–43) mentioned
above, only a handful of other phosphoramidate nucleotide antibiotics have been identified to
date. A series of phosphoramidate nucleotide antibiotics called phosmidosines (phosmidosine (45),
phosmidosine B (46), and phosmidosine C (47)) and two variants of N-methylphosmidosine (48, 49)
were isolated from the culture filtrate of Streptomyces durhameusis [271,296]. Phosmidosines appear
to inhibit spore formation of Botrytis cinerea at the concentration of 0.25 µg/mL. Botrytis cinerea is
a worldwide pathogenic fungus responsible for the grey mold disease in a variety of commercially
important fruits and vegetables [271,296]. A series of isolated in vitro studies also suggested
phosmidosines as potential anticancer agents [270,297–299].
Molecules 2019, 24, x FOR PEER REVIEW 19 of 66 
 
were isolated from the culture filtrate of Streptomyces durhameusis [271,296]. Phosmidosines appear to 
inhibit spore formation of Botrytis cinerea at the concentration of 0.25 µg/mL. Botrytis cinerea is a 
worldwide pathogenic fungus responsible for the grey mold disease in a variety of commercially 
important fruits and vegetables [271,296]. A series of isolated in vitro studies also suggested 
phosmidosines as potential anticancer agents [270,297–299]. 
 
Microcin C 3  (50) and microcin C-like (e.g., 52) peptide phosphoramidate antibiotics are 
members of a large family of ribosomally synthetized peptides that are produced by many species of 
bacteria, including cyanobacteria, both marine and terrestrial [300–303]. Virtually all of identified 
homologs of microcin C peptides contain a heptapeptide moiety together with the C-terminally 
attached adenosine phosphoramidate moiety (50). So far the only well studied exceptions from that 
rule are microcin C-like peptides from Bacillus amyloliquefaciens and Yersinia pseudotuberculosis which 
contain carboxymethyl-cytidine [304,305]. Natural antibiotics from the microcin C family are the so 
called “Trojan horse inhibitors” of aspartyl tRNA synthetases. The structure [306,307], genetics [308], 
biosynthesis [309–312], the antibacterial mechanism of action [313,314] and regulation of activity 
[315–318] of microcin C family of antibiotics was extensively reviewed before and will not be 
expanded upon here [319,320]. In short a peptide moiety (of variable length and amino acid 
composition depending on the organism of origin [303]) is responsible for the active transport of the 
inhibitory moiety part (phosphoramidate aspartyl-nucleoside, 51, and 53) into the bacterial cell. The 
phosphoramidate linkage is more stable to the hydrolysis, as compared to the labile native aspartyl-
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shown to be identical and are referred as microcin C) (50) and microcin C-like (e.g., 52) peptide
phosphoramidate antibiotics are members of a large family of ribosomally synthetized peptides that are
produced by many species of bacteria, including cyanobacteria, both marine and terrestrial [300–303].
Virtually all of identified homologs of microcin C peptides contain a heptapeptide moiety together
with the C-terminally attached adenosine phosphoramidate moiety (50). So far the only well
studied exceptions from that rule are microcin C-like peptides from Bacillus amyloliquefaciens
and Yersinia pseudotuberculosis which contain carboxymethyl-cytidine [304,305]. Natural antibiotics
from the microcin C family are the so called “Trojan horse inhibitors” of aspartyl tRNA synthetases.
The structure [306,307], genetics [308], biosynthesis [309–312], the antibacterial mechanism of
action [313,314] and regulation of activity [315–318] of microcin C family of antibiotics was extensively
reviewed before and will not be expanded upon here [319,320]. In short a peptide moiety (of variable
length and amino acid composition depending on the organism of origin [303]) is responsible for
the active transport of the inhibitory moiety part (phosphoramidate aspartyl-nucleoside, 51, and 53)
into the bacterial cell. The phosphoramidate linkage is more stable to the hydrolysis, as compared to
the labile native aspartyl-adenylate [314]. As a result the phosphoramidate “Trojan horse inhibitor”
is capable of specific targeting of the aspartyl-tRNA synthetase and subsequent cessation of protein
synthesis [314].
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from, e.g., Escherichia coli.
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nucleotide antibiotics are also known, including two hydroxylamines that contain a biologically 
unprecedented tract of six heteroatoms in a row (54, 55). Antibiotics EM 2487 (54) and 1100-50 (55) 
were isolated from Streptomyces sp. Mer-2487 and Streptomyces lavendulae SANK 64297, respectively 
[321–323]. Antibiotics 1100-50 and EM2487 differ in their nucleoside substructure composition. 
EM2487 contains a uridine ring while 1100-50 has a cytidine instead. In addition, EM2487 contains 
an N-methylated hydroxylamine group, while the hydoxylamine group of 1100-50 is not N-
methylated. Both EM2487 and 1100-50 were tested as potential anti-HIV and nematocide agents 
respectively [321–323]. The third known phosphoramidate pyrimidine nucleotide antibiotic—
antibiotic HC 62 (56)—was isolated from Bacillus sp. HC-62 [324]. 
Apart from microcin C-like peptide antibiotics three other phosphoramidate pyrimidine
nucleotide antibiotics are also known, including two hydroxylamines that contain a biologically
unprecedented tract of six heteroatoms in a row (54, 55). Antibiotics EM 2487 (54) and 1100-50
(55) were isolated from Streptomyces sp. Mer-2487 and Streptomyces lavendulae SANK 64297,
respectively [321–323]. Antibiotics 1100-50 and EM2487 differ in their nucleoside substructure
composition. EM2487 contains a uridine ring while 1100-50 has a cytidine instead. In addition,
EM2487 contains an N-methylated hydroxylamine group, while the hydoxylamine group of 1100-50 is
not N-methylated. Both EM2487 and 1100-50 were tested as potential anti-HIV and nematocide agents
respectively [321–323]. The third known phosphoramidate pyrimidine nucleotide antibiotic—antibiotic
HC 62 (56)—was isolated from Bacillus sp. HC-62 [324].
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a phosphoramidate P–N bond-containing PTM (for general overview of phosphoramidate modification
of proteins see work of Besant, Attwood and others [328–332]).
The general acid lability of phosphoramidate PTMs in proteins meant that the progress on
the identification of those protein modifications has been very slow and for decades only few
scattered examples of P–N bond containing proteins from variety of organisms were known.
Recent breakthroughs in biochemical and analytical methods of detection of N-phosphorylated
proteins has resulted in the discovery of many more P–N bond containing PTMs, showing that
the persisting view on the rarity of the P–N phosphoramidate bond in the core biochemistry of
life is an artifact of the established, standard biochemical methods of detection (which are still
often implemented today). For example, the standard purification and identification procedures
for phosphor-proteins use an acid treatment. O-phosphorylated proteins are generally stable in acid
conditions [333], but phosphoramidate proteins are not. Such bias in identification methods led to
the O-phosphorylated proteins to be detected and, as a consequence, studied much more often than
their N-phosphorylated counterparts. Hence over the years the N-phosphorylated proteins have been
largely overlooked and the true extent of the utilization of the phosphoramidate P–N bond in cellular
metabolism could not have been reliably assessed [328,331,334,335]. Likewise, the enzymes catalyzing
the formation (kinases) and hydrolysis (phosphatases) of P–N bonds remained largely uncharacterized.
2.2.1. N-phosphorylation of L-arginine
There are several sporadic, early reports describing protein arginine kinase activity, responsible
for N-phosphorylation of specific arginine residues (57) in specific proteins. Those early studies
particularly focused on identification of arginine N-phosphorylation in vertebrate tissues.
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In recent research, a growing body of experimental evidence suggests that arginine
N-phosphorylation is an abundant protein posttranslational modification in both eukaryotes
and prokaryotes. Recently, a combined mutational and mass spectrometric studies of protein tyrosine
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phosphatase B (PtpB)-deficient Staphylococcus aureus (PtpB is also an putative arginine phosphatase)
showed that the number of putative arginine phosphorylation sites in proteome of Staphylococcus aureus
alone exceeds 200 [341,342]. N-phosphoarginine post-translational modifications span proteins
involved in virtually all metabolic processes of Staphylococcus aureus, from the energy metabolism
and protein biosynthesis to the regulation of transcription and oxidative stress [341,342].
Only recently a detailed functional characterization of an arginine kinase (McsB protein arginine
kinase (EC 2.7.14.1) from Gram-positive bacteria) was attempted [343,344]. For a short overview on
the discovery of McsB protein arginine kinase see a summary by Suskiewicz and Clausen [345].
Protein arginine kinase McsB and its respective protein arginine phosphatase YwlE constitute
a redox-sensitive kinase–phosphatase switch regulating the bacterial response to oxidative stress [346].
During oxidative stress, the two cysteine residues present in the active site of YwlE form a disulfide
S–S bridge. The formation of the S–S bridge shuts down enzymatic activity of the phosphatase.
The redox inactivation of YwlE leads to accumulation of N-phosphorylated arginine residues in
proteins (due to uninterrupted activity of the McsB arginine kinase). For example, the accumulation
of N-phosphorylated arginine residues leads to the inactivation of the transcription factor CtsR
which under normal conditions represses expression of stress response genes in bacterial cells.
The McsB-mediated N-phosphorylation of specific arginine residues in CtsR transcription factor
prevents it from binding to the DNA, which in turn enhances the expression of the antistress response
genes [343,347]. CtsR is likely not the only substrate for the McsB/YwlE kinase-phosphatase pair.
Large numbers of N-phosphorylated arginine proteins were identified in Bacillus subtilis, many of
them are transcription factors as well [348,349]. Similarly to results obtained for Staphylococcus aureus,
N-phosphorylation of arginine residues in Bacillus subtilis proteins may be much more widespread
and may play much more global role than previously assumed.
It is important to note that many of the putative or confirmed sites of arginine N-phosphorylation
appear to participate in protein–DNA interactions. Arginine is one of the main amino acid residues
that is involved in formation of protein–DNA interaction interfaces. One study suggests that as much
as one-third of residues protein–DNA interfaces is arginine [350]. It logical to suggest that protein
arginine N-phosphorylation could be an important means of regulating protein–DNA association.
Being positively charged arginine is well suited for formation of tight electrostatic interactions with
negatively charged phosphate backbone of the DNA. N-phosphorylation of arginine side chains allows
for reverting of the net positive charge and therefore promoting the dissociation of proteins from their
target DNA sequences. One may make an interesting general comparison between the three different
charge states of arginine PTMs (N-methylation, conversion to citrulline, and N-phosphorylation)
and speculate on the possible regulatory interplay between them [351]. While the N-methylation
of arginine residues generally stabilizes the positive charge, the N-phosphorylation is not merely
removing it (as it is in the case of a conversion to citrulline) but it reverts the charge, diametrically
changing the properties of the modified residue.
Arginine is also crucial in mediating of many protein–protein interactions; thus, it is entirely
possible that N-phosphorylation of arginine residues could also regulate protein–protein interactions,
and not only in preventing such interactions, one can envision a mechanism in which a specific
N-phosphorylated arginine residue works as molecular recognition platform for proteins that recognize
such modified residues in a specific manner. Indeed at least one such case is known—ClpCP
protease—which recognizes proteins with N-phosphorylated arginine residues and targets them
for degradation. As shown by the recent study, arginine N-phosphorylation of proteins mediated by
the McsB kinase is also involved in targeting of substrate proteins for degradation in Gram-positive
bacteria [344]. Such complex regulation and diverse roles of this PTM further solidify the emerging
picture of arginine N-phosphorylation as one of the central regulatory mechanisms in the physiology
of the cell.
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2.2.2. N-phosphorylation of L-lysine
There are two different types of lysine N-phosphorylation that were detected as post-translational
modifications (PTMs) on proteins. In both of them a phosphoramidate P–N bond is formed as a result
of lysine N-phosphorylation. The first phosphoramidate PTM, where a single phosphate group
is transferred to the nitrogen atom of the side chain of the target lysine residue, is called lysine
N-monophosphorylation (58). The second described protein posttranslational modification involving
lysine N-phosphorylation is called lysine N-polyphosphorylation (59), a covalent modification in
which inorganic chains of polyphosphate are attached to lysine residues of target proteins. We describe
both of them below.
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Lysine N-monophosphorylation: Out of the three amino acids that were shown to be
N-phosphorylated in vivo, N-monophospholysine (58) is the least studied. N-monophospholysine
was initially described many decades ago in partially purified rat liver cell extracts [352,353].
While several early studies have suggested the presence of N-monophospholysine residues in
proteins in vivo (e.g., lysine N-monophosphorylation in histone H1 [337,354,355]) and some studies
even eluded to the identification of specific lysine kinases [356] and phosphatases [357–360],
including PHPT1 histidine phosphatase (see Section 2.2.3 for more information on N-phosphorylation
of histidine) that was shown to dephosphorylate chemically phosphorylated N-monophospholysines
of histone H1 in vitro [361], the lack of reliable mass spectroscopy techniques to study this PTM
have significantly limited our understanding of the function and the extent of this modification
in the cell. The functions of N-monophosphorylation of lysine residues in a handful of known
examples (e.g., the role of N-monophosphorylation of lysine in histone H1) is currently unknown [331].
However, recent advances in synthetic chemistry and mass spectrometric methods might allow for
easier detection and characterization study of N-monophosphorylation of lysine residues in vitro
and in vivo [362–364]. Some recent isolated studies suggest that the N-monophosphorylation of
lysines could be a widespread phenomenon in biochemistry [365,366], indeed the apparent rarity of
N-monophospholysine in biological systems might be only due to its notorious detection difficulty
and not to the fact that N-monophosphorylated lysines are rare.
Lysine polyphosphorylation: The problem of robust detection of N-phosphorylated lysine residues
is not limited solely to N-monophospholysines. It is accepted that only a very small fraction of
lysine post-translational modifications have been identified experimentally [367]. Recent studies
detected an unusual PTM associated with lysine residues present within acidic protein regions.
Such lysine residues appear to have very long chains of inorganic polyphosphates covalently
attached to the amino group of the lysine side chain (59) [332,368,369]. Once attached to the target
lysine residue the inorganic polyphosphates polymer can reach a length of tens if not hundreds of
phosphate monomer units [370,371]. A number of lysine N-polyphosphorylation targets have been
identified in common budding yeast (Saccharomyces cerevisiae). The N-polyphosphorylated proteins
in Saccharomyces cerevisiae include a nuclear signal recognition 1 (Nsr1) and its interacting protein
topoisomerase 1 (Top1) [368], as well as 15 lysine N-polyphosphorylation protein substrates with
functions related to ribosome biogenesis. N-polyphosphorylated proteins were also identified in
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human cells. For example, six PASK-domain containing target proteins were identified as targets for
lysine N-polyphosphorylation [372]. The PASK-domain (poly acidic-, serine-, and lysine-rich sequence)
appears to be a characteristic of N-polyphosphorylated proteins. The exact role of the PASK domains
and N-polyphosphorylation is not understood although it is known that polyphosphates in general
(not necessarily N-polyphosphates) participate in a variety of processes ranging from regulating core
metabolism to structural roles [370]. It was recently suggested that polyphosphates are one of the key
factors required for cell survival after DNA damage in eukaryotic cells [373]. It is therefore intriguing
to speculate if N-polyphosphorylation also participates in these processes.
One of the most interesting possibilities is a potential interplay of N-polyphosphorylation
of lysine residues with other PTMs that target lysine residues. For example, lysine sumoylation
requires recognition sequence similar to the PASK domain. Lysine sumoylation could, in principle,
target the same lysine residues and compete for them with N-polyphosphorylation [332]. Such complex
interplay and competition between PTMs is not unheard of and was shown, e.g., for the N-terminal
modifications of proteins (see below, Section 2.2.4 [374,375]).
Similar competition and interplay can also happen with serine pyrophosphorylation, even if
N-polyphosphorylation and serine pyrophosphorylation are targeted towards different residues.
Lysine N-polyphosphorylation is under indirect control of the levels of inositol pyrophosphates [368].
The most important function of the inositol pyrophosphate in the cell is the regulation of the levels
of polyphosphates, and by extension the regulation of the levels of available ATP [376–379].
The connection between the inositol pyrophosphate and lysine N-phosphorylation opens the possibility
of a complex interplay between lysine N-polyphosphorylation and serine pyrophosphorylation,
because serine pyrophosphorylation is directly dependent on inositol pyrophosphate levels in
the cell [380–382].
We conclude Section 2.2.2. by emphasizing that despite the fact that very little is known about
the cellular functions of N-phosphorylation of lysine residues, recent breakthroughs in a variety of
analytical techniques, especially mass spectrometry, are likely to revolutionize the N-phospholysine
detection and characterization, hopefully also leading to an unambiguous detection of lysine kinases
and phosphatases. So far, no in vivo specific lysine N-phosphorylating kinases nor N-dephosphorylating
phosphatases have been identified [362].
2.2.3. N-phosphorylation of L-histidine
The third of the phosphoramidate P–N bond-containing post-translational modifications (PTMs)
of proteins known to exist is N-phosphorylation of histidine. The research on N-phosphorylation
of histidine (and arginine and lysine as well) gained a lot of momentum recently with the rapid
development of the new biochemical and analytical techniques aimed at thorough identification of
the P–N bond modified amino acids in proteins. Development of specific anti-N-phosphohistidine
antibodies, thanks to successful synthesis of acid-stable N-phosphohistidine analogs, and recent new
mass spectroscopic approaches open the possibility for deeper understanding of the distribution of
N-phosphohistidine. This understanding has in turn illuminated N-phosphohistidine biochemistry
and cell biology, and its emerging roles in virtually all main cellular processes including cell cycle
regulation, regulation of ion channel activity (e.g., in immune response), phagocytosis, or metal ion
coordination (e.g., Cu(II)). As a result of the reinvigorated interest in N-phosphorylation of histidine,
especially in mammalian systems, a series of excellent reviews were published that thoroughly
cover the chemistry, identification and cellular functions of N-phosphohistidine, we will therefore
only focus on a brief summary of the topic, referring the reader to the excellent recent literature
summaries. For general reviews on the state of the N-phosphohistidine biology, see work by
Klumpp, Besant, Fuhs and others [334,383–386] for its chemical properties and identification methods
and see work by Attwood, Besant, Kee and others [329,335,387–389] for its enzyme-catalyzed formation
(N-phosphohistidine kinases (EC 2.7.13.3), including the formation of N-phosphohistidine as a reaction
intermediate in enzymes such as nucleoside diphosphate kinase (EC 2.7.4.6)) and hydrolysis
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(N-phosphohistidine phosphatases (EC 3.9.1.3)) of N-phosphohistidine residues see work by Besant,
Attwood, Wieland and others [390–394].
The N-phosphohistidine as PTM exists in the form of two isomers 1- and 3-N-phosphohistidines
(60, 61), the third possibility 1,3-N’N’-diphosphohistidine (62) so far was not reported to be made by
life, and may be unstable under physiological conditions [395].
Molecules 2019, 24, x FOR PEER REVIEW 27 of 66 
 
 
Similarly to N-phosphoarginine and N-phospholysine, N-phosphohistidine is an acid-labile 
PTM [329]. It is only recently with the development of new approaches in detection of N-
phosphohistidine and other N-phosphorylated amino acids that the true extent and the detailed roles 
of the phosphoramidate modification of proteins can be assessed. 
It is now widely accepted that the histidine N-phosphorylation is a crucial component of cell 
signaling in all domains of life. The crucial role of N-phosphohistidine was first associated with 
regulation of rapid ‘canonical’ signaling pathways like the bacterial phosphoenolpyruvate–sugar 
phosphotransferase system (PTS), the reactions catalyzed by enzymes such as nucleoside 
diphosphate kinase and succinyl–CoA synthetase [396–398] or a well-studied ‘two-component’ 
system in bacteria and archaea [385,394,399]. Recently it became apparent that the N-phosphorylation 
of histidine residues is also a crucial component of many signaling pathways in eukaryotic cells, 
including fungi, plants, and animals, e.g., in the immune system in mammals [400–402]. Interestingly 
in mammalian proteins, the N-phosphorylation of histidine often happens at either 1-N or 3-N 
positions of the histidine imidazole ring (60, 61), depending on the source of the kinase (EC 2.7.13.3), 
this of course adds to the complexity of the detection and identification of this modification in the 
mammalian cells [383]. The aberration in N-phosphohistidine homeostasis was also implicated in 
human diseases such as cancer or inflammation [403,404]. 
The overall occurrence of N-phosphohistidine in living organisms is currently estimated to be 
quite high, both in bacterial and archaeal cells as well as in eukaryotes. Recent studies suggest that 
N-phosphohistidine constitutes up to 10% of the total phosphorylation events in the eukaryotic cell 
[405], which makes the P–N bond-containing N-phosphohistidine 10 to 100 times more abundant 
than the well-studied O-phosphotyrosine (but less abundant than O-phosphoserine [334]). 
Having established that the N-phosphohistidine is a central chemical modification of proteins in 
all of life, with hundreds of putative targets identified, the main focus of the N-phosphohistidine 
biology is directed towards identification of kinases and phosphatases that specifically regulate the 
N-phosphohistidine proteome. So far apart from a handful of prokaryotic kinases, only two 
mammalian histidine kinases (NME1 and NME2) [393] and three phosphatases (PHPT1 [406,407], 
LHPP [408], and PGAM5 [400]) were identified. It is certain that with the implementation of the new 
biochemical and analytical methods focused on identification of acid-labile phosphoramidate bond 
more N-phosphohistidine-dependent enzymes await discovery, not to mention the likely surge in the 
number of new confirmed N-phosphorylation targets. 
Similarly to N-phosphoarginine and N-phospholysine, N-phosphohistidine is an acid-labile PTM [329].
It is only recently with the development of new approaches in detection of N-phosphohistidine and other
N-phosphorylated amino acids that the true extent and the detailed roles of the phosphoramidate
modification of proteins can be assessed.
It is now widely accepted that the histidine N-phosphorylation is a crucial component of cell
signaling in all domains of life. The crucial role of N-phosphohistidine was first associated with
regulation of rapid ‘canonical’ signaling pathways like the bacterial phosphoenolpyruvate–sugar
phosphotransferase system (PTS), the reactions catalyzed by enzymes such as nucleoside diphosphate
kinase and succinyl–CoA synthetase [396–398] or a well-studied ‘two-component’ system in bacteria
and archaea [385,394,399]. Recently it became apparent that the N-phosphorylation of histidine
residues is also a crucial component of many signaling pathways in eukaryotic cells, including fungi,
plants, and animals, e.g., in the immune system in mammals [400–402]. Interestingly in mammalian
proteins, the N-phosphorylation of histidine often happens at either 1-N or 3-N positions of the histidine
imidazole ring (60, 61), depending on the source of the kinase (EC 2.7.13.3), this of course adds to
the complexity of the detection and identification of this modification in the mammalian cells [383].
The aberration in N-phosphohistidine homeostasis was also implicated in human diseases such
as cancer or inflammation [403,404].
The overall occurrence of N-phosphohistidine in living organisms is currently estimated to be
quite high, both in bacterial and archaeal cells as well as in eukaryotes. Recent studies suggest
that N-phosphohistidine constitutes up to 10% of the total phosphorylation events in the eukaryotic
cell [405], which makes the P–N bond-containing N-phosphohistidine 10 to 100 times more abundant
than the well-studied O-phosphotyrosine (but less abundant than O-phosphoserine [334]).
Having established that the N-phosphohistidine is a central chemical modification of proteins
in all of life, with hundreds of putative targets identified, the main focus of the N-phosphohistidine
biology is directed towards identification of kinases and phosphatases that specifically regulate
Molecules 2019, 24, 866 28 of 66
the N-phosphohistidine proteome. So far apart from a handful of prokaryotic kinases, only two
mammalian histidine kinases (NME1 and NME2) [393] and three phosphatases (PHPT1 [406,407],
LHPP [408], and PGAM5 [400]) were identified. It is certain that with the implementation of the new
biochemical and analytical methods focused on identification of acid-labile phosphoramidate bond
more N-phosphohistidine-dependent enzymes await discovery, not to mention the likely surge in
the number of new confirmed N-phosphorylation targets.
2.2.4. N-phosphorylation of Other Amino Acids?
The emerging view of N-phosphorylation of arginine, lysine and histidine as widespread
post-translational modifications (PTMs) utilized by virtually all clades of life opens an interesting
possibility for N-phosphorylation of other nitrogen-containing functional groups in proteins.
Those potentially include N-phosphorylation of the nitrogen in the indole ring of tryptophan;
N-phosphorylation of the amide nitrogen in asparagine and glutamine; or α-N-terminal phosphorylation
of the α-amino groups on the N-terminal amino acid residues in proteins. We discuss the possibility of
biological occurrence of those N-phosphorylated species below.
The N-phosphotryptophan was successfully synthetized [409,410]. However, the N-phosphorylation
of the indole ring of the tryptophan residue is so far unknown to occur naturally. In principle
the N-phosphorylation of tryptophan residues is possible and was speculated on before [330]. The reasons
for the apparent absence of the N-phosphorylated tryptophan can be two-fold. First, the bulkiness of
the residue and its general hydrophobicity causes tryptophan side chains to be often buried deep within
protein folds. This in turn might limit their overall accessibility towards putative N-phosphotryptophan
kinases, not to mention the addition of a charged group to a buried hydrophobic residue could severely
disrupt the overall protein fold. Secondly, it was also postulated that the required deprotonation of
the indole nitrogen, before the phosphorylation reaction can occur, might be difficult to accommodate
under physiological conditions [329,330].
The N-phosphorylation of L-asparagine or L-glutamine amide groups in proteins is also unknown.
While the formation of the N-phospho-L-glutamine (16) was shown for the individual amino
acid as a biosynthetic intermediate (see (Figure 3) and Section 2.1 for an in depth discussion of
N-phospho-L-glutamine (16)) [47] the first N-phosphoasparagine or N-phosphoglutamine PTM still
awaits discovery. The degree of physiological stability of such protein modification is also unknown.
Similarly, despite the fact that α-N-phosphorylated amino acids (both as free residues and in
peptides) are widely-known to organic chemists, there have been no reports of α-N-phosphorylated
amino acids in biological systems. This absence of α-N-phosphorylation of proteins is surprising.
In the cell there is no shortage of free and accessible protein α-N-terminal amino groups that could
potentially undergo such phosphorylation.
Interestingly, many α-N-terminal PTMs are known to exist (for reviews see work by
Tooley and Varland [411,412]), including α-N-terminal methylation [375,413,414], α-N-terminal
acetylation [415,416], α-N-terminal propionylation [417], or α-N-terminal myristoilation/
palmitoylation [418] to name a few, but the natural occurrence of α-N-terminal phosphorylation
remains to be proven. There is also an intriguing possibility for such α-N-terminal modifications to
be dynamic and interchangeable (on the same protein target) in a highly regulated manner [411].
Evidence for such interchangeability of α-N-terminal PTMs was recently suggested for myosin
regulatory light chain 9 (MYL9), the first protein that can be either N-terminally acetylated or
N-terminally methylated [374,375]. It is interesting to speculate if such complex regulation of
α-N-terminal PTMs also, to any extent, involves α-N-phosphorylation.
Such speculations do have merit, especially in light of the fact that α-N-terminally phosphorylated
amino acids were postulated as one of the precursors in pre-biotic chemistry in several origin
of life scenarios [419–430]. α-N-terminally phosphorylated amino acids can self-polymerize into
oligopeptides under appropriate conditions. This chemical reactivity made them attractive candidates
for possible intermediates in the prebiotic synthesis of the polymers of life [419,422,424–426,428,429].
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Several pathways for the origin and coevolution of nucleic acids and proteins, involving α-N-terminally
phosphorylated amino acids, were also proposed in an attempt to identify a common pre-biotic
chemical building blocks for peptides and nucleic acids [419,421,425,426,428]. If such involvement of
α-N-terminally phosphorylated amino acids at the origin of life indeed took place it is possible that
some remnants of this chemistry still persist in modern biochemistry to this day.
However, so far despite all of the rich chemistry and possible intricate interplay between various
α-N-terminal PTMs the biologically relevant occurrence of α-N-phosphorylation still remains to be
discovered. It is very possible that, similarly to their N-phosphorylated side chain counterparts,
α-N-phosphorylated peptides are acid-labile and transient regulatory species in the cell. If this is the case
their detection would require specialized targeted-proteomics approaches, not unlike those applied to
specifically identify S-phosphocysteine proteome (see work by Bertran-Vicente [431] and Section 3.2 for
more information on S-phosphorylation of L-cysteine).
3. Natural Products Containing a P–S Bond (Phosphorothioates)
Interestingly natural products containing P–S double or P–S single bonds (phosphorothiones
and thiophosphates respectively) are almost entirely absent form biochemistry. Apart from two
instances of small molecule natural products (Section 3.1), S-phosphocysteine in several proteins
(Section 3.2) and bacterial phosphorothioate DNA modification (Section 3.3) the P–S bond is not
utilized by life. Such scarcity of P–S bond in biochemistry is in a direct contrast to a plethora of
P–S compounds utilized in human industry. Phosphorothiones and thiophosphates are particularly
popular as pesticides and herbicides. Compounds containing P–S bonds (double or single) are one
of the most common functional groups found in chemicals utilized in agrochemistry. The number of
phosphorothiones and thiophosphates utilized in agriculture alone is in the hundreds [432].
3.1. Small-Molecule Natural Products Containing a P–S Bond
Natural products containing a P–S bond are extremely rare in biochemistry. To date, there are only
two reported cases, of chemically-related, P–S natural products known. The phosphorus-containing
phosphorothione hydrazone (63) was isolated from the red tide dinoflagellate Karenia brevis near
the coast of Florida and was identified as an ichthyotoxin [433]. It was also shown to exhibit acute
toxicity towards rodents [434,435]. The second known small molecule natural phosphorothione is
a dimerized form of the phosphorothione (63). Compound 64 was isolated from a marine fungus
Lignincola laevis and also exhibits cytotoxic properties [436].
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to acidic conditions than phosphoramidates such as phosphohistidine [330]) [437]; S-phosph rylated
cysteine (65) is very prone to hydrolytic cleavage of the phosphothioester bond at acidic pH [330,431],
e.g., at pH 3–4 the half-life of the s t i st r bond does not exceed 15 min at 37 ◦C [330,
437]. It is important to note as well that certai metal ions (like Cu(II) or Ag(I)) cat lyze P–S bond
hydrolysis [437]. At the first glance the hydrolytic lability of phosphothioester bond at acidic pH
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might be viewed as a serious obstacle to its use in biochemistry, and one of the reasons behind
the apparent rarity of phosphothioesters in life. It is important to note however that S-phosphocysteine
and other S-substituted phosphorothioic acids are very stable at basic pH (>7 up to 12). This chemical
characteristic can open the possibility of utilization of stable S-phosphorylated cysteine residues in cell
signaling or catalysis when the local cellular microenvironment (e.g., within the fold of the protein) is
favorable. Indeed, as we briefly review below, the utilization of S-phosphocysteine in the regulation of
a variety of cellular processes is likely much more wide spread than previously thought.
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The single bond between phosphorous and sulfur (P–S bond) in S-phosphocysteine is
widely-known to be present as a common enzymatic reaction intermediate and much less
as a standalone post-translational modification of proteins. For example, widely reported instances
of cysteine phosphorylation come from the studies of the catalytic mechanism of cysteine-dependent
protein phosphatases (CDPs), especially protein tyrosine phosphatases (PTPs) [438–441]. PTPs
catalyze the hydrolysis of phosphoester bonds with the formation of a S-phosphocysteine intermediate
and are strictly specific towards phosphotyrosine-containing substrates. In PTPs a reactive, conserved
catalytic cysteine thioate acts as a nucleophile and attacks the phosphorus atoms of the substrate
phosphotyrosine [439,442]. The S-phosphocysteine intermediate catalytic state was detected in
the crystal structure of a well-studied tyrosine phosphatase PTP1B (It is important to note that catalytic
cysteine residue of PTP1B undergoes complex redox regulation, with the formation of interesting N–S
bond-containing cyclic sulfenamide 1,2-thiazolidin-3-one [18,19]. Such redox regulation of the activity
of catalytic cysteines protects them from detrimental effects of irreversible oxidation. More research is
needed to uncover how does the cysteine S-phosphorylation fit within the broad redox metabolism of
cysteine residues in the cell) [439].
It is only recently that S-phosphorylation of cysteine is recognized outside of its role
as a catalytic intermediate and is identified more widely as a potentially important regulatory
modification of proteins (for other recent overviews of this topic please see excellent work of Piggott,
Attwood and Buchowiecka [330,437]). Recent reports that follow a series of early studies that
identified S-phosphocysteine residue in the EIIB component of the phosphoenolpyruvate-dependent
sugar transporter system in Escherichia coli [443–446] slowly add more examples of regulatory
S-phosphorylation to the cellular repertoire.
For example, members of a transcriptional regulator family SarA/MgrA from Staphylococcus
aureus undergo reverse phosphorylation of the conserved cysteine residue. The presence of
the S-phosphocysteine in the SarA/MgrA transcriptional regulator was linked to the regulation
of the virulence of the Staphylococcus aureus [447]. Apart from the S-phosphocysteine on the EIIB
component of the bacterial phosphoenolpyruvate-dependent sugar transporter system SarA/MgrA
(mentioned above) is so far the only confirmed instance of the S-phosphorylation of the regulatory
cysteine residue.
The S-phosphorylation and S-dephosphorylation of SarA/MgrA regulatory cysteine residue is
catalyzed by eukaryotic-like serine/threonine kinase (Stk1) and phosphoserine/phosphothreonine protein
phosphatase (Stp1), respectively. Moreover, as shown by Sun and others [447], the S-phosphorylation
of the cysteine residue in SarA/MgrA is inhibited by reactive oxygen species, due to cysteine oxidation.
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This observation is in agreement with the previous report that showed that SarA/MgrA transcriptional
regulators are redox-regulated by reactive oxygen species released by the host immune system
as a response to the microbial attack [448]. Thus, it appears that the connection between cysteine
oxidation and S-phosphorylation requires a complex interplay between kinase/phosphatase activity
regulation and the global cellular redox-state control. If S-phosphorylation of cysteine residues is routinely
catalyzed by known serine/threonine kinases and phosphatases, as the SarA/MgrA case suggests,
then the possibility that cysteine S-phosphorylation is much more common in the cell is quite likely.
In addition to the studies summarized above, one phosphoproteome analysis reported
S-phosphorylation of Cys63 of rat heart sarcomeric mitochondrial creatine kinase [449]. The function
the S-phosphorylation of this partially conserved residue is unknown.
In fact, novel mass spectrometric techniques aimed specifically at the detection of S-phopshocysteine
were recently demonstrated [431]. The analysis reported by Bertran-Vicente [431] allows for a definitive
identification of S-phosphocysteine in MS/MS spectra. Such technological breakthroughs open
the possibility for the true assessment of the extent of utilization of S-phosphocysteine in cellular
metabolism. It is likely that in the upcoming years regulatory S-phosphorylation of proteins will stop
being treated as a rather obscure protein post-translational modification and will be recognized as one of
the important regulatory signals in the metabolism of the cell.
3.3. Phosphorothioate DNA Modifications
The decades long, canonical view suggests that the basic repeating units of the DNA polymer
are essentially composed of three residues: a purine or pyrimidine base, deoxyribose sugar,
and a phosphate group, which are in turn composed of five (out of six) biogenic elements (hydrogen,
carbon, oxygen, nitrogen, and phosphorus), leaving the sixth biogenic element—sulfur—out of
the genetic material of life. Indeed, the absence of sulfur in the material injected by phage T2 into
Escherichia coli cells was a Nobel Prize-winning part of the evidence that DNA and not protein
was the genetic material [450]. This long-standing dogma was shattered with the relatively recent
discovery of the phosphorothioation of bacterial DNA (e.g., 66). The discovery of phosphorothioates
(residues where the ionized, nonbonding oxygen atom of the phosphate group in the DNA backbone is
replaced by sulfur) in bacterial DNA proved that sulfur’s role in building polymers of life is not solely
limited to proteins. It appears that, at least in bacteria, sulfur is also crucial for maintaining normal
functions of genetic material of life [451]. Contrary to all other known modifications of DNA and RNA,
phosphorothioation of DNA is so far the only known natural modification of the phospho-sugar
backbone of DNA.
Molecules 2019, 24, x FOR PEER REVIEW 31 of 66 
 
In addition to the studies summarized above, one phosphoproteome analysis reported S-
phosphorylation of Cys63 of rat heart sarcomeric mitochondrial creatine kinase [449]. The function 
the S-phosphorylation of this partially conserved residue is unknown. 
In fact, novel mass spectrometric techniques aimed specifically at the detection of S-
phopshocysteine were recently demonstrated [431]. The analysis reported by Bertran-Vicente [431] 
allows for a definitive identification of S-phosphocysteine in MS/MS spectra. Such technological 
breakthroughs open the possibility for the true assessment of the extent of utilization of S-
phosphocysteine in cellular metabolism. It is likely that in the upcoming years regulatory S-
phosphorylation of proteins will stop being treated as a rather obscure protein post-translational 
modification and will be recognized as one of the important regulatory signals in the metabolism of 
the cell. 
3.3. Phosphorothioate DNA Modifications 
The decades long, canonical view suggests that the basic repeating units of the DNA polymer 
are essentially composed of three residues: a purine or pyrimidine base, deoxyribose sugar, and a 
phosphate group, which are in turn composed of five (out of six) biogenic elements (hydrogen, 
carbon, oxygen, nitrogen, and phosphorus), leaving the sixth biogenic element—sulfur—out of the 
genetic material of life. Indeed, the absence of sulfur in the material injected by phage T2 into 
Escherichia coli cells was a Nobel Prize-winning part of the evidence that DNA and not protein was 
the genetic material [450]. This long-standing dogma was shattered with the relatively recent 
discovery of the phosphorothioation of bacterial DNA (e.g., 66). The discovery of phosphorothioates 
(residues where the ionized, nonbonding oxygen atom of the phosphate group in the DNA backbone 
is replaced by sulfur) in bacterial DNA proved that sulfur’s role in building polymers of life is not 
solely limited to proteins. It appears that, at least in bacteria, sulfur is also crucial for maintaining 
normal functions of genetic material of life [451]. Contrary to all other known modifications of DNA 
and RNA, phosphorothioation of DNA is so far the only known natural modification of the phospho-
sugar backbone of DNA. 
 
The detailed functions, genetics, physiology, and biosynthesis of phosphorothioation of the 
bacterial DNA were reviewed very recently and will only be highlighted briefly here. For detailed, 
excellent review on this unusual modification please see work of Wang and others [452]. 
The prolific studies by Wang and colleagues identified phosphorothioation to be sequence-
specific (requiring conserved core sequences d(GPSA), d(GPSG), d(CPSC), d(GPST), d(APSC), d(TPSC), 
and flanking sequences), stereospecific (RP diastereoisomer configuration), as well as being 
postreplicative (i.e., the DNA is modified after it is synthesized). The phosphorothioate modification 
(PT) is regulated by the dnd operon gene cluster, consisting of five genes dndABCDE [453,454]. 
Molecules 2019, 24, 866 32 of 66
The detailed functions, genetics, physiology, and biosynthesis of phosphorothioation of
the bacterial DNA were reviewed very recently and will only be highlighted briefly here. For detailed,
excellent review on this unusual modification please see work of Wang and others [452].
The prolific studies by Wang and colleagues identified phosphorothioation to be sequence-specific
(requiring conserved core sequences d(GPSA), d(GPSG), d(CPSC), d(GPST), d(APSC), d(TPSC),
and flanking sequences), stereospecific (RP diastereoisomer configuration), as well as being
postreplicative (i.e., the DNA is modified after it is synthesized). The phosphorothioate modification
(PT) is regulated by the dnd operon gene cluster, consisting of five genes dndABCDE [453,454].
Phosphorothioation appears to be a very common phenomenon in phylogenetically diverse bacteria,
with diverse sequence specificities and variable occurrence in different bacterial genomes [454,455].
So far, phosphorothioathion appears to be uniquely bacterial feature and was not detected in
Eukaryotes and Archaea. See [456] and [452] for detailed summary of the genetics of the dnd cluster in
various bacterial organisms.
Phosphorothioate DNA modification is synthetized by proteins DndA, C, D and E. It is postulated
that the sulfur in PT modification is derived from desulfurization of cysteine by DndA. The rest of
the synthetic mechanism is unknown.
As expected, and initially shown, the main PT function is as a component of the bacterial
DNA restriction modification (r-m) defense system [457]. The bacterial r-m system also includes
specialized endonucleases (type IV ScoMcrA) which specifically recognize foreign PT DNA [458].
Recent studies expanded the roles of PT DNA modification and showed that the cellular functions
of phosphorothiation are much more versatile. It is now believed that PT is also involved in
multiple cellular processes unrelated to defense against foreign DNA, including response to oxidative
stress and balancing of the redox state of the cell [459,460] or involvement in epigenetic control of
gene expression [461,462] and protection of DNA from double-stranded breaks [463]. For detailed
information on the roles of PT in the bacterial cell see recent excellent review by Wang and others [452].
Endogenous phosphorothioate DNA restriction modification system was discovered only about
a decade ago and many details regarding its genetics, enzymology and physiological function
(both regarding bacterial defense mechanisms against foreign DNA invasion but also regarding many
other newly discovered roles) are still unknown (see a review by Wang and others [452] for the most
up to date state of research on PT DNA modification). We will conclude this section by outlining three
outstanding questions regarding P–S bond formation in genetic polymers of life that in our view are
the most fundamental and interesting ones:
1) Is PT modification of DNA a uniquely bacterial feature, or is it also present in Archaea
and Eukarya? So far, no such modifications were detected in Archaean and Eukaryotic genomes.
2) DNA modifications are dynamic (e.g., DNA methylation and demethylation cycles crucial for
normal functioning of the Eukaryotic cell). Is PT modification reversible or convertible in any way after
implementation into bacterial DNA? So far there is no evidence for that and no enzyme responsible for
removal of PT modifications was identified.
3) Is RNA is also modified by introduction of PT modifications? So far approximately 160 RNA
modifications were discovered [327]. RNA is much more widely modified than DNA and so far, all
the modifications identified in DNA were always eventually also found in RNA.
4. Natural Products Containing a P–C Bond
We conclude our overview of the natural products containing rare organophosphorus functional
groups with a brief summary on the natural compounds containing a P–C bond. Phosphonates
and phosphinates were studied extensively over the years and thoroughly reviewed very recently [464].
We will therefore cover phosphonate (Section 4.1) and phosphinate (Section 4.2) biochemistry only
briefly, providing an overview of structural diversity of compounds belonging to these two classes of
compounds. We conclude Section 4 with an overview of the rarely discussed and generally neglected
topic of biochemistry of trivalent phosphorous compounds (Section 4.3). In Section 4.3 we review
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the extensive evidence that anaerobic life on Earth makes phosphine gas (PH3), a simplest trivalent
phosphorous compound. We also explore the possibility that there may be other more complex
phosphines made by life to be discovered.
For the ‘at-a-glance’ summary of the structural diversity of P–C bond containing natural products
see list of molecules and their biological sources below: phosphonates (67–117), phosphinates (118–131),
and phosphines (132, 134).
4.1. Phosphonates
The P–C bond of phosphonates is one of the most stable bonds in biochemistry, much more
stable than the analogous P–O bond. For example, 2-aminoethyl phosphonic acid (72), the first
natural product containing a P–C bond to be discovered, is highly stable to hydrolysis, even by
strong acids, highly thermally stable, and even stable to combustion [464]. Moreover, phosphonates
are a class of chemicals known from their ability to inhibit many crucial biochemical pathways by
mimicking phosphate monoesters and carboxylates in various metabolic processes. Such molecular
mimicry of crucial metabolic intermediates is essentially possible due to two features: (1) highly
chemically stable P–C bond and (2) a close overall structural resemblance of phosphonates to common
biochemicals (e.g., phosphate esters or carboxylates). Those two features make phosphonates a great
choice as targeted enzyme inhibitors, used both by nature (as natural antibiotics) and synthetic
chemists alike.
At the first glance phosphonates can be considered an oddity of biochemistry. However, life on
Earth appears to widely recognize phosphonates’ potential as carriers of useful biological function.
A great variety of phosphonates have been isolated from virtually all clades of life: animals
(including humans), fungi, plants, protozoans, archaea, and bacteria [464,465]. Natural phosphonates
constitute both small molecule metabolites (see the structural overview of phosphonates (67–117)
below) as well as phosphonylated macromolecules such as lipids, polysaccharides and glycoproteins
(We note that, so far, despite many discoveries of diverse phosphonoglycoproteins a direct
phosphonylation of proteins i.e. formation of a P–C bond-containing post-translationally modified
amino acids in the peptide backbone is not known to exist) [465]. The wide extent of utilization
of P–C bond-containing phosphonates by life is exemplified by the fact that in some organisms
P–C compounds form the vast majority of cellular phosphorus-containing molecules (e.g., in eggs
of a fresh water snail Helisoma 95% of phosphorus-containing compounds constitutes complex
phosphonoglycans; in sea anemone Urticina crassicornis 50% is in the form of phosphonoglycans,
phosphonoglycoproteins, and phosphonolipids; in Tetrahymena pyriformis 30% of membrane lipids is
in the form of phosphonolipids [464,465]).
Therefore, phosphonates could be an underappreciated source of phosphorus in the global
phosphorus cycle (for an excellent summary on the role of phosphonates in the global phosphorus
cycle see work of McGrath [466]); especially in the marine environment where phosphorus is a main
limiting nutrient. Recent studies on the cycling of phosphorus in the marine environment suggest
that dissolved organophosphorus compounds are an important alternative source of the element for
ocean life. A significant fraction (~25%) of the organophosphorus compounds dissolved in ocean
water are compounds containing C–P bonds [467,468]. For example, the elemental composition
of the cultured strains of cyanobacterium Trichodesmium erythraeum showed that up to 10% of
the entire particulate phosphorous pool is contained in the form of P–C bond containing compounds
(i.e., phosphonates) [469]. Since cyanobacteria are ubiquitous inhabitants of the marine environment
it is not surprising that significant fraction of environmental phosphorus could be deposited in
the form of phosphonates, which in turn can be utilized as a significant source of phosphorus
by the rest of the marine biosphere. The importance of the P–C bond containing compounds,
especially phosphonates in the global phosphorous cycle is supported by the metagenomic studies
from the Global Ocean Survey on P–C bond biosynthesis and catabolism [470]. A significant
number of marine microbial organisms appear to contain genetic clusters responsible for phosphonate
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biosynthesis (~10% of bacterial genomes studied) and coding for enzymatic pathways for hydrolysis
of the P–C bond-containing compounds (~30% of collected bacterial genomes) [470].
As in the case of other rare organophosphorus natural compounds and biochemicals the true
extent of the utilization of the P–C bond by life can only recently be properly assessed, in most part
thanks to the multiple breakthroughs in environmental metagenomic techniques. Initial metagenomic
studies on phosphonate biochemistry suggest that both their biosynthetic and catabolic pathways
appear to be common and very diverse. Unfortunately, just like in the case of P–N bond-containing
phosphoramidates, P–S bond-containing phosphorothioates or phosphines (see Section 4.3 below,
for more information on the biochemistry of trivalent phosphorous compounds), the scarcity of suitable
in situ detection, identification and quantification techniques for the P–C bond containing compounds
hampers the progress in biochemistry of this important class of compounds.
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4.2. Phosphinates 
Phosphinates are a very rare class of natural products. The most well described group among 
them are several peptide antibiotics (118–126) containing a unique phosphinate amino acid 
phosphinothricin (118). They were isolated from various species of Actinobacteria including 
Streptomyces viridochromogenes and Streptomyces hygroscopicus (e.g., 123) as well as Kitasatospora 
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and Streptomyces hygroscopicus (e.g., 123) as well as Kitasatospora phosalacinea (e.g., 125). The identification
and biosynthesis of natural phosphinate antibiotics was reviewed before on many occasions and is not
going to be expanded any further [464,465,471,472].
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least some of phosphine production in the environment could be the result of energy capture 
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Phosphine (as well as other reduced phosphorus species such as phosphite (133)) have been also 
found associated with feces and flatus from many animals including termites [483], penguins [484], 
cattle, pigs [485], and humans [486]. Guts are typically completely anaerobic, with anaerobic bacteria 
outnumbering aerobic bacteria [487–489], even in guts as small as those of earthworms [490] or 
termites [491]. 
Finally, several studies have reported phosphine production from mixed bacterial cultures in 
the laboratory [492,493]. One study claimed conversion of half the phosphorus in the culture medium 
(~180mg/L) into phosphine in 56 days [475]. The detailed biosynthetic pathway for microbial 
phosphine production is currently unknown. For detailed discussion of the biological production in 
the environment, its biochemistry, and atmospheric chemistry see three recent papers by Bains, 
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only one such compound other than phosphine has been identified. This compound is a cyclic alkyl
phosphine phospholane (134), found in European badger (Meles meles) feces [496]. The detection
of phospholane was carefully validated, and so it likely to be a genuine product of metabolism of
anaerobic badger gut microbiome and not an anthropogenic contaminant. Feces are a highly anaerobic
environment, so this detection supports the association of trivalent phosphorus metabolism with
strictly anoxic environments.
We believe that there could be other biological trivalent phosphorus compounds awaiting
discovery. The large majority of ‘natural products’ (i.e., chemicals made by life) are identified from
aerobic samples—plants, animals, soil fungi, and Ascomycetes grown in aerated culture—as well
as marine organisms [494]. Very few are collected from anaerobic samples, in part because of
the received wisdom among natural product chemists that anaerobic organisms do not produce
secondary metabolites [497]. The biological production of phosphine and phospholane shows that
terrestrial life can indeed make trivalent phosphorus compounds, and suggests that it only does
so in highly anoxic environments. We suggest that a more systematic search of the compounds
made by organisms in completely anoxic environments will find other, more complex trivalent
phosphorus compounds.
5. Conclusions and Future Directions
We have reviewed the occurrence, biological roles, and biosynthesis (if known) of nonphosphate
biochemicals including P–N (phosphoramidate) (Section 2), P–S (phosphorothioate) (Section 3),
and P–C (Section 4). We have also summarized the biochemistry of phosphorylation of ‘unusual’ amino
acids in proteins (N- and S-phosphorylation), chemical modifications common in both prokaryotes
and eukaryotes. We have also collected and summarized studies on the natural phosphorothioate
(P–S) and phosphoramidate (P–N) modifications of DNA and nucleotides, a topic which is not widely
covered in the literature.
Our review illustrates the diversity and centrality of the phosphorus metabolism in all life on
Earth, and shows that life’s reliance on phosphorus goes well beyond phosphate. We further illustrate
that fact by emphasizing the phylogenetic diversity of organisms making compounds containing
nonphosphate phosphorus, showing that nonphosphate biochemicals are not a rare specialism of a few
organisms but rather a crucial part of all of biochemistry.
Finally, our exhaustive review has shown that the extent of utilization by life of some of
the ‘noncanonical’ phosphorus-containing functional groups (e.g., P–N bonds) was likely severely
underestimated and largely overlooked over the years due to the technical difficulties associated
with identification of nonphosphate natural compounds, meaning that their apparent rarity is
probably an artifact. We hope that this review stimulates further research into this interesting class of
natural compounds.
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